Patients Rising Now signed onto a letter to the Federal Trade Commission (FTC) regarding Pharmacy Benefit Managers (PBMs) with 105 other associations. This was a letter we signed onto in addition to the comments we submitted on behalf of our own organization. The PBM issue is so critical to patient access to care that we wanted to take any opportunity we could to support the call for reform!
Categories
- Access
- Advocacy
- California
- Comment Letters
- Copay Accumulators
- Copay Assistance
- COVID-19
- Drug Costs
- FDA
- Featured
- Featured Action
- Federal Issues
- Health Insurance
- Health Policy
- ICER
- Illinois
- Issues
- Letters Submitted
- Letters Supported
- Massachusetts
- Medicaid
- Medicare
- Medicare Part D
- News
- Op-Ed
- Out of Pocket Costs
- Pharmacy Benefit Managers
- Podcast
- Prescription Drugs
- Press Releases
- Public Statement
- QALY
- State Issues
- Statements
- Step Therapy
- Surprise Billing
- Uncategorized
- Value Based Insurance Design
- Value Frameworks
- Virtual Advocacy Chat
Tags
21st Century Cures Act
340B
Access to Care
Advocacy
Alzheimer's
Biden Administration
biosimilars
Cancer
cms
Copay Accumulators
copay assistance
COVID-19 Vaccine
drug costs
Drug Manufacturing
Drug Pricing
drug rebate
fail first
FDA
Gene Therapies
H.R.3
Health Insurance
hospital bills
HR 3708
hsa
ICER
Insurance design
Joe Biden
medicare Part B
medicare part D
Mental Health
Nonmedical Switching
open enrollment
Out of Pocket Costs
PBM
PBMs
pharmacy benefit managers
Price Transparency
Prior Authorization
QALY
Rare Disease
Right to Repair
Step Therapy
Telehealth
transparency
Value Framework
Recent Posts
- Wilcox: A Bipartisan Victory for Patients to Ban Discriminatory Metrics Congressional Subcommittee Agrees: Patient Lives are WORTH IT
- Patients Rising Now Submits Comments on Patient Rights to United States Patent and Trademark Office
- New Harris Poll: FDA Should Regulate All Medical Device Service and Repair
- Patient Impact Report: Discrimination Faced by Patients with Rare Diseases
- Are States Prepared for the End of COVID-19 Emergency Declarations?